Brief: Rhythm Pharmaceuticals Q1 Net Income USD -55.639 Million Vs. IBES Estimate USD -55.3 Million
05/05/2026 12:00
May 05 (Reuters) - Rhythm Pharmaceuticals Q1 operating income USD -52.361 million. Q1 product revenue USD 60.112 million
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand